Lax S

No ORCID on file · 4 papers in corpus
2023
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2023-004429

In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of pat…

2023
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
Virchows Archiv : an international journal of pathology ·doi:10.1007/s00428-023-03552-3

In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of pat…

review 2014
[Mucinous ovarian neoplasms. Prognostically mostly excellent, infrequently a wolf in sheep's clothing]
Der Pathologe ·doi:10.1007/s00292-014-1912-4

Mucinous ovarian neoplasms represent the second largest group of epithelial ovarian tumors after serous neoplasms, of which benign cystadenomas constitute more than 80 %. Mucinous cystadenomas and carcinomas cannot be distinguished by the c…

2013
Targeting signaling pathways in epithelial ovarian cancer.
International journal of molecular sciences ·doi:10.3390/ijms14059536

UnlabelledOvarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-based chemotherapy is poor in some patients and, thus, current research is focusing on new therapy options. The various histological types of…